✦ LIBER ✦

Metabolism of N -[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trial

✍ Scribed by Philip C. Schofield; Iain G. C. Robertson; James W. Paxton; Michael R. McCrystal; Barrie D. Evans; Philip Kestell; Bruce C. Baguley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma pharmacokinetics of N -[2-(dimeth

✍ Philip Kestell; Ingrid C. Dunlop; Michael R. McCrystal; Barrie D. Evans; James W 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 120 KB

Phase I study of the cytotoxic agent N -

✍ Michael R. McCrystal; Barrie D. Evans; Vernon J. Harvey; Paul I. Thompson; David 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 115 KB

Rat hepatocyte-mediated metabolism of th

✍ Schlemper, B.; Siegers, D. J.; Paxton, J. W.; Robertson, I. G. C. 📂 Article 📅 1993 🏛 Informa plc 🌐 English ⚖ 258 KB

Structure−Activity Relationships for Acr

✍ Spicer, Julie A.; Gamage, Swarna A.; Atwell, Graham J.; Finlay, Graeme J.; Bagul 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 267 KB

Inter-species variation in the metabolis

✍ Philip C Schofield; Iain G.C Robertson; James W Paxton 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 208 KB

The potential of N-[2-(dimethylamino)eth

✍ R. A. Davey; Gloria M. Su; Rebecca M. Hargrave; Rozelle M. Harvie; Bruce C. Bagu 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 196 KB